aluates Reports

$ 0.0

Automative

Global Cytology and HPV Testing Market Research Report 2026

Published Date: 2026-04-22

Report Code: QYRE-Auto-36A9848

Global Cytology and HPV Testing Market Insights Forecast to 2028

BUY CHAPTERS

Global Cytology and HPV Testing Market Research Report 2026

Code: QYRE-Auto-36A9848

Report

2026-04-22

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Cepheid Inc

Hologic Inc

Qiagen NV

Thermo Fisher Scientific

Roche Diagnostics

Bio Rad

Hybribio

Kingmed Diagnostics

bioMérieux

BGI Group

Seegene

DAAN Gene

Cytology and HPV Testing Market Size

The global Cytology and HPV Testing market was valued at US$ 4984 million in 2025 and is anticipated to reach US$ 8222 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Cytology and HPV Testing Market

Cytology Testing, taking the exfoliated cells of the cervix and vagina to determine the possibility of cervical and vaginal precancerous lesions. And HPV Testing is to screen viruses, detect whether there is human papillomavirus in vaginal secretions, especially high-risk human papillomavirus; Cytology Testing has high specificity but poor sensitivity, HPV Testing has strong sensitivity but poor specificity; HPV Testing It can be used as an effective supplement to Cytology Testing, and the combined screening of the two is conducive to improving screening efficiency and increasing the accuracy of Hospitals & Clinics.

Global key players of Cytology and HPV Testing include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, etc. The top four players hold a share over 40%. North America is the largest market, has a share about 41%, followed by Europe, and Asia-Pacific, with share 26% and 22%, separately. In terms of product type, Consumables is the largest segment, occupied for a share of 58%, and in terms of application, Hospitals & Clinics has a share about 58%.

This report delivers a comprehensive overview of the global Cytology and HPV Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cytology and HPV Testing. The Cytology and HPV Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cytology and HPV Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cytology and HPV Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Cytology and HPV Testing Market Report

Report Metric	Details
Report Name	Cytology and HPV Testing Market
Accounted market size in 2025	US$ 4984 million
Forecasted market size in 2032	US$ 8222 million
CAGR	7.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Instruments Consumables Services
Segment by Application	Hospitals & Clinics Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, Hologic, BD, Hybribio, KingMed Diagnostics, Abbott, bioMérieux, Cepheid, BGI Group, Seegene, Daan Gene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cytology and HPV Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Cytology and HPV Testing Market growing?

Ans: The Cytology and HPV Testing Market witnessing a CAGR of 7.5% during the forecast period 2026-2032.

What is the Cytology and HPV Testing Market size in 2032?

Ans: The Cytology and HPV Testing Market size in 2032 will be US$ 8222 million.

What is the market share of major companies in Cytology and HPV Testing Market?

Ans: The top four players hold a share over 40%.

What is the Cytology and HPV Testing Market share by region?

Ans: North America is the largest market, has a share about 41%, followed by Europe, and Asia-Pacific, with share 26% and 22%, separately.

What is the Cytology and HPV Testing Market share by type?

Ans: In terms of product type, Consumables is the largest segment, occupied for a share of 58%, and in terms of application, Hospitals & Clinics has a share about 58%.

Who are the main players in the Cytology and HPV Testing Market report?

Ans: The main players in the Cytology and HPV Testing Market are Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, Hologic, BD, Hybribio, KingMed Diagnostics, Abbott, bioMérieux, Cepheid, BGI Group, Seegene, Daan Gene

What are the Application segmentation covered in the Cytology and HPV Testing Market report?

Ans: The Applications covered in the Cytology and HPV Testing Market report are Hospitals & Clinics, Laboratories, Others

What are the Type segmentation covered in the Cytology and HPV Testing Market report?

Ans: The Types covered in the Cytology and HPV Testing Market report are Instruments, Consumables, Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cytology and HPV Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Instruments

1.2.3 Consumables

1.2.4 Services

1.3 Market by Application

1.3.1 Global Cytology and HPV Testing Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals & Clinics

1.3.3 Laboratories

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cytology and HPV Testing Market Perspective (2021–2032)

2.2 Global Cytology and HPV Testing Growth Trends by Region

2.2.1 Global Cytology and HPV Testing Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Cytology and HPV Testing Historic Market Size by Region (2021–2026)

2.2.3 Cytology and HPV Testing Forecasted Market Size by Region (2027–2032)

2.3 Cytology and HPV Testing Market Dynamics

2.3.1 Cytology and HPV Testing Industry Trends

2.3.2 Cytology and HPV Testing Market Drivers

2.3.3 Cytology and HPV Testing Market Challenges

2.3.4 Cytology and HPV Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cytology and HPV Testing Players by Revenue

3.1.1 Global Top Cytology and HPV Testing Players by Revenue (2021–2026)

3.1.2 Global Cytology and HPV Testing Revenue Market Share by Players (2021–2026)

3.2 Global Top Cytology and HPV Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Cytology and HPV Testing Revenue

3.4 Global Cytology and HPV Testing Market Concentration Ratio

3.4.1 Global Cytology and HPV Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cytology and HPV Testing Revenue in 2025

3.5 Global Key Players of Cytology and HPV Testing Head Offices and Areas Served

3.6 Global Key Players of Cytology and HPV Testing, Products and Applications

3.7 Global Key Players of Cytology and HPV Testing, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Cytology and HPV Testing Breakdown Data by Type

4.1 Global Cytology and HPV Testing Historic Market Size by Type (2021–2026)

4.2 Global Cytology and HPV Testing Forecasted Market Size by Type (2027–2032)

5 Cytology and HPV Testing Breakdown Data by Application

5.1 Global Cytology and HPV Testing Historic Market Size by Application (2021–2026)

5.2 Global Cytology and HPV Testing Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Cytology and HPV Testing Market Size (2021–2032)

6.2 North America Cytology and HPV Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Cytology and HPV Testing Market Size by Country (2021–2026)

6.4 North America Cytology and HPV Testing Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cytology and HPV Testing Market Size (2021–2032)

7.2 Europe Cytology and HPV Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Cytology and HPV Testing Market Size by Country (2021–2026)

7.4 Europe Cytology and HPV Testing Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Cytology and HPV Testing Market Size (2021–2032)

8.2 Asia-Pacific Cytology and HPV Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Cytology and HPV Testing Market Size by Region (2021–2026)

8.4 Asia-Pacific Cytology and HPV Testing Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Cytology and HPV Testing Market Size (2021–2032)

9.2 Latin America Cytology and HPV Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Cytology and HPV Testing Market Size by Country (2021–2026)

9.4 Latin America Cytology and HPV Testing Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cytology and HPV Testing Market Size (2021–2032)

10.2 Middle East & Africa Cytology and HPV Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Cytology and HPV Testing Market Size by Country (2021–2026)

10.4 Middle East & Africa Cytology and HPV Testing Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Cytology and HPV Testing Introduction

11.1.4 Thermo Fisher Scientific Revenue in Cytology and HPV Testing Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Roche Diagnostics

11.2.1 Roche Diagnostics Company Details

11.2.2 Roche Diagnostics Business Overview

11.2.3 Roche Diagnostics Cytology and HPV Testing Introduction

11.2.4 Roche Diagnostics Revenue in Cytology and HPV Testing Business (2021–2026)

11.2.5 Roche Diagnostics Recent Development

11.3 QIAGEN

11.3.1 QIAGEN Company Details

11.3.2 QIAGEN Business Overview

11.3.3 QIAGEN Cytology and HPV Testing Introduction

11.3.4 QIAGEN Revenue in Cytology and HPV Testing Business (2021–2026)

11.3.5 QIAGEN Recent Development

11.4 Bio-rad

11.4.1 Bio-rad Company Details

11.4.2 Bio-rad Business Overview

11.4.3 Bio-rad Cytology and HPV Testing Introduction

11.4.4 Bio-rad Revenue in Cytology and HPV Testing Business (2021–2026)

11.4.5 Bio-rad Recent Development

11.5 Hologic

11.5.1 Hologic Company Details

11.5.2 Hologic Business Overview

11.5.3 Hologic Cytology and HPV Testing Introduction

11.5.4 Hologic Revenue in Cytology and HPV Testing Business (2021–2026)

11.5.5 Hologic Recent Development

11.6 BD

11.6.1 BD Company Details

11.6.2 BD Business Overview

11.6.3 BD Cytology and HPV Testing Introduction

11.6.4 BD Revenue in Cytology and HPV Testing Business (2021–2026)

11.6.5 BD Recent Development

11.7 Hybribio

11.7.1 Hybribio Company Details

11.7.2 Hybribio Business Overview

11.7.3 Hybribio Cytology and HPV Testing Introduction

11.7.4 Hybribio Revenue in Cytology and HPV Testing Business (2021–2026)

11.7.5 Hybribio Recent Development

11.8 KingMed Diagnostics

11.8.1 KingMed Diagnostics Company Details

11.8.2 KingMed Diagnostics Business Overview

11.8.3 KingMed Diagnostics Cytology and HPV Testing Introduction

11.8.4 KingMed Diagnostics Revenue in Cytology and HPV Testing Business (2021–2026)

11.8.5 KingMed Diagnostics Recent Development

11.9 Abbott

11.9.1 Abbott Company Details

11.9.2 Abbott Business Overview

11.9.3 Abbott Cytology and HPV Testing Introduction

11.9.4 Abbott Revenue in Cytology and HPV Testing Business (2021–2026)

11.9.5 Abbott Recent Development

11.10 bioMérieux

11.10.1 bioMérieux Company Details

11.10.2 bioMérieux Business Overview

11.10.3 bioMérieux Cytology and HPV Testing Introduction

11.10.4 bioMérieux Revenue in Cytology and HPV Testing Business (2021–2026)

11.10.5 bioMérieux Recent Development

11.11 Cepheid

11.11.1 Cepheid Company Details

11.11.2 Cepheid Business Overview

11.11.3 Cepheid Cytology and HPV Testing Introduction

11.11.4 Cepheid Revenue in Cytology and HPV Testing Business (2021–2026)

11.11.5 Cepheid Recent Development

11.12 BGI Group

11.12.1 BGI Group Company Details

11.12.2 BGI Group Business Overview

11.12.3 BGI Group Cytology and HPV Testing Introduction

11.12.4 BGI Group Revenue in Cytology and HPV Testing Business (2021–2026)

11.12.5 BGI Group Recent Development

11.13 Seegene

11.13.1 Seegene Company Details

11.13.2 Seegene Business Overview

11.13.3 Seegene Cytology and HPV Testing Introduction

11.13.4 Seegene Revenue in Cytology and HPV Testing Business (2021–2026)

11.13.5 Seegene Recent Development

11.14 Daan Gene

11.14.1 Daan Gene Company Details

11.14.2 Daan Gene Business Overview

11.14.3 Daan Gene Cytology and HPV Testing Introduction

11.14.4 Daan Gene Revenue in Cytology and HPV Testing Business (2021–2026)

11.14.5 Daan Gene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Cepheid Inc

Hologic Inc

Qiagen NV

Thermo Fisher Scientific

Roche Diagnostics

Bio Rad

Hybribio

Kingmed Diagnostics

bioMérieux

BGI Group

Seegene

DAAN Gene

List of Tables

Table 1. Global Cytology and HPV Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Instruments

Table 3. Key Players of Consumables

Table 4. Key Players of Services

Table 5. Global Cytology and HPV Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Cytology and HPV Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Cytology and HPV Testing Market Size by Region (US$ Million), 2021–2026

Table 8. Global Cytology and HPV Testing Market Share by Region (2021–2026)

Table 9. Global Cytology and HPV Testing Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Cytology and HPV Testing Market Share by Region (2027–2032)

Table 11. Cytology and HPV Testing Market Trends

Table 12. Cytology and HPV Testing Market Drivers

Table 13. Cytology and HPV Testing Market Challenges

Table 14. Cytology and HPV Testing Market Restraints

Table 15. Global Cytology and HPV Testing Revenue by Players (US$ Million), 2021–2026

Table 16. Global Cytology and HPV Testing Market Share by Players (2021–2026)

Table 17. Global Top Cytology and HPV Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cytology and HPV Testing Revenue, 2025

Table 18. Ranking of Global Top Cytology and HPV Testing Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Cytology and HPV Testing Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Cytology and HPV Testing, Headquarters and Area Served

Table 21. Global Key Players of Cytology and HPV Testing, Products and Applications

Table 22. Global Key Players of Cytology and HPV Testing, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Cytology and HPV Testing Market Size by Type (US$ Million), 2021–2026

Table 25. Global Cytology and HPV Testing Revenue Market Share by Type (2021–2026)

Table 26. Global Cytology and HPV Testing Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Cytology and HPV Testing Revenue Market Share by Type (2027–2032)

Table 28. Global Cytology and HPV Testing Market Size by Application (US$ Million), 2021–2026

Table 29. Global Cytology and HPV Testing Revenue Market Share by Application (2021–2026)

Table 30. Global Cytology and HPV Testing Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Cytology and HPV Testing Revenue Market Share by Application (2027–2032)

Table 32. North America Cytology and HPV Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Cytology and HPV Testing Market Size by Country (US$ Million), 2021–2026

Table 34. North America Cytology and HPV Testing Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Cytology and HPV Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Cytology and HPV Testing Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Cytology and HPV Testing Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Cytology and HPV Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Cytology and HPV Testing Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Cytology and HPV Testing Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Cytology and HPV Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Cytology and HPV Testing Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Cytology and HPV Testing Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Cytology and HPV Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Cytology and HPV Testing Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Cytology and HPV Testing Market Size by Country (US$ Million), 2027–2032

Table 47. Thermo Fisher Scientific Company Details

Table 48. Thermo Fisher Scientific Business Overview

Table 49. Thermo Fisher Scientific Cytology and HPV Testing Product

Table 50. Thermo Fisher Scientific Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 51. Thermo Fisher Scientific Recent Development

Table 52. Roche Diagnostics Company Details

Table 53. Roche Diagnostics Business Overview

Table 54. Roche Diagnostics Cytology and HPV Testing Product

Table 55. Roche Diagnostics Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 56. Roche Diagnostics Recent Development

Table 57. QIAGEN Company Details

Table 58. QIAGEN Business Overview

Table 59. QIAGEN Cytology and HPV Testing Product

Table 60. QIAGEN Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 61. QIAGEN Recent Development

Table 62. Bio-rad Company Details

Table 63. Bio-rad Business Overview

Table 64. Bio-rad Cytology and HPV Testing Product

Table 65. Bio-rad Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 66. Bio-rad Recent Development

Table 67. Hologic Company Details

Table 68. Hologic Business Overview

Table 69. Hologic Cytology and HPV Testing Product

Table 70. Hologic Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 71. Hologic Recent Development

Table 72. BD Company Details

Table 73. BD Business Overview

Table 74. BD Cytology and HPV Testing Product

Table 75. BD Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 76. BD Recent Development

Table 77. Hybribio Company Details

Table 78. Hybribio Business Overview

Table 79. Hybribio Cytology and HPV Testing Product

Table 80. Hybribio Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 81. Hybribio Recent Development

Table 82. KingMed Diagnostics Company Details

Table 83. KingMed Diagnostics Business Overview

Table 84. KingMed Diagnostics Cytology and HPV Testing Product

Table 85. KingMed Diagnostics Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 86. KingMed Diagnostics Recent Development

Table 87. Abbott Company Details

Table 88. Abbott Business Overview

Table 89. Abbott Cytology and HPV Testing Product

Table 90. Abbott Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 91. Abbott Recent Development

Table 92. bioMérieux Company Details

Table 93. bioMérieux Business Overview

Table 94. bioMérieux Cytology and HPV Testing Product

Table 95. bioMérieux Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 96. bioMérieux Recent Development

Table 97. Cepheid Company Details

Table 98. Cepheid Business Overview

Table 99. Cepheid Cytology and HPV Testing Product

Table 100. Cepheid Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 101. Cepheid Recent Development

Table 102. BGI Group Company Details

Table 103. BGI Group Business Overview

Table 104. BGI Group Cytology and HPV Testing Product

Table 105. BGI Group Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 106. BGI Group Recent Development

Table 107. Seegene Company Details

Table 108. Seegene Business Overview

Table 109. Seegene Cytology and HPV Testing Product

Table 110. Seegene Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 111. Seegene Recent Development

Table 112. Daan Gene Company Details

Table 113. Daan Gene Business Overview

Table 114. Daan Gene Cytology and HPV Testing Product

Table 115. Daan Gene Revenue in Cytology and HPV Testing Business (US$ Million), 2021–2026

Table 116. Daan Gene Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Cytology and HPV Testing Picture

Figure 2. Global Cytology and HPV Testing Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Cytology and HPV Testing Market Share by Type: 2025 vs 2032

Figure 4. Instruments Features

Figure 5. Consumables Features

Figure 6. Services Features

Figure 7. Global Cytology and HPV Testing Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Cytology and HPV Testing Market Share by Application: 2025 vs 2032

Figure 9. Hospitals & Clinics Case Studies

Figure 10. Laboratories Case Studies

Figure 11. Others Case Studies

Figure 12. Cytology and HPV Testing Report Years Considered

Figure 13. Global Cytology and HPV Testing Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Cytology and HPV Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Cytology and HPV Testing Market Share by Region: 2025 vs 2032

Figure 16. Global Cytology and HPV Testing Market Share by Players in 2025

Figure 17. Global Cytology and HPV Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Cytology and HPV Testing Revenue in 2025

Figure 19. North America Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Cytology and HPV Testing Market Share by Country (2021–2032)

Figure 21. United States Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Cytology and HPV Testing Market Share by Country (2021–2032)

Figure 25. Germany Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Cytology and HPV Testing Market Share by Region (2021–2032)

Figure 33. China Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Cytology and HPV Testing Market Share by Country (2021–2032)

Figure 41. Mexico Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Cytology and HPV Testing Market Share by Country (2021–2032)

Figure 45. Israel Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Cytology and HPV Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 49. Roche Diagnostics Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 50. QIAGEN Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 51. Bio-rad Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 52. Hologic Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 53. BD Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 54. Hybribio Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 55. KingMed Diagnostics Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 56. Abbott Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 57. bioMérieux Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 58. Cepheid Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 59. BGI Group Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 60. Seegene Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 61. Daan Gene Revenue Growth Rate in Cytology and HPV Testing Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HPV DNA Test Market Insights Forecast to 2030

Global Cervical Cancer Screening Market Research Report 2024

Global Cervical Screening System Market Research Report 2024

Global HPV Testing and Pap Test Market Research Report 2025

Global HPV and PAP Testing Market Research Report 2024

Global HPV Test Preservation Solution Market Research Report 2024

Global Cervical Cell Analysis System Market Research Report 2025

Global Pap Tests and HPV Tests Market Research Report 2024

Cervical Cancer Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HPV Sample Storage Solution Market Research Report 2024

Global HPV Testing and Pap Smear Testing Market Research Report 2024

Global HPV Screening Test and Pap Test Market Research Report 2024

Human Papilloma Virus Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HPV18 High Risk with 16 18 Genotyping PCR Test Kit Market Research Report 2024

Global HPV Test Reagent kit Market Research Report 2024

Global Colposcopy Market Insights Forecast to 2030

Global Liquid based Cytology Slide Scanner Market Research Report 2025

Global Cervical Biopsy Equipment Market Research Report 2024

Global Cytology Reagent Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions